Cochrane Evidence Synthesis and Methods ►

Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone for women with platinum-sensitive recurrent epithelial ovarian cancer.

This is a protocol.

Published:

27 June 2024

Authors:

Pappa C, Galaal K, Smyth S, Bristow RE, Khashan AS, Alazzam M

See the full Review on

the Cochrane Library

►

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Pappa C, Galaal K, Smyth S, Bristow RE, Khashan AS, Alazzam M. Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer (Protocol). Cochrane Database of Systematic Reviews 2024, Issue 6. Art. No.: CD015297. DOI: 10.1002/14651858.CD015297.